ADORA2A and renal cell carcinoma: A2AR expression was also up‐regulated in tumor tissues of patients with renal cell carcinoma and was significantly associated with renal cell carcinoma metastasis, resistance to immune‐targeted therapy, and shortened overall survival (OS).52